Eli Lilly
1,525 hedge funds and large institutions have $83.2B invested in Eli Lilly in 2019 Q3 according to their latest regulatory filings, with 93 funds opening new positions, 511 increasing their positions, 627 reducing their positions, and 73 closing their positions.
27% more first-time investments, than exits
New positions opened: 93 | Existing positions closed: 73
1% more funds holding
Funds holding: 1,516 → 1,525 (+9)
0% less capital invested
Capital invested by funds: $83.2B → $83.2B (-$35.8M)
0.42% less ownership
Funds ownership: 77.55% → 77.13% (-0.42%)
5% less call options, than puts
Call options by funds: $457M | Put options by funds: $482M
19% less repeat investments, than reductions
Existing positions increased: 511 | Existing positions reduced: 627
20% less funds holding in top 10
Funds holding in top 10: 25 → 20 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$874M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$579M |
| 3 |
CG
Carmignac Gestion
Paris,
France
|
+$112M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$101M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$84.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$417M |
| 2 |
Renaissance Technologies
New York
|
-$239M |
| 3 |
APG Asset Management
Amsterdam,
Netherlands
|
-$225M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$190M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$166M |
LLY Hedge Fund Activity: Q3 2019 in Review
1,525 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q3 2019, worth a combined $83.2B — down 0.04% from $83.2B a quarter earlier.
Buyers outnumbered sellers: 93 funds opened new LLY positions and 73 closed out — a net gain of 20 holders — while 511 added to existing stakes and 627 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $874M. The largest seller was T. Rowe Price Associates, cutting an estimated $417M.
- 1,525 institutional investors held Eli Lilly (LLY) as of Q3 2019, up from 1,516 in Q2 2019.
- Funds reported $83.2B of Eli Lilly stock for Q3 2019, down 0.04% quarter-over-quarter.
- 93 funds opened new Eli Lilly positions in Q3 2019 and 73 closed out, a net change of +20 holders.
- The largest Eli Lilly buyer in Q3 2019 was Wellington Management Group, an estimated $874M added.
- The largest Eli Lilly seller in Q3 2019 was T. Rowe Price Associates, an estimated $417M sold.
Based on aggregated 13F filings for Q3 2019.